“In my 43 year involvement in organized dentistry, the presenting of a myriad and multitude of Continuing Education programs has been a primary function. FACES programs on Botox and Dermal Filler have far exceeded my greatest expectations. Dr. Meinecke’s presentation exhibited not only her knowledge and background in this area but her attention to detail and hands on one-on-one instruction for each injector and patient was above and beyond the norm.”
– Charles H. Perle, DMD, FAGD; Executive Director, New Jersey Academy of General Dentistry
“The botox and dermal filler course was informative. Dr. Meinecke was knowledgeable and helpful. The atmosphere was friendly and conducive to learning. Very well organized and interesting. Can’t wait to use it in the office! Also, I am looking forward to the next course by Dr. Meinecke and NJAGD.”
– Sanjeev Satwah, DMD, FAGD
Dr. Gigi Meinecke has been active in the field of facial injectables since 2004 and has been teaching the subject since 2010. She serves on the AGD Legislative and Governmental Affairs Council, is a National Spokesperson and Chairs the AGD/ASDA Task Force. Dr. Meinecke also serves on the ADA Council on Communications. She received her RN BSN from The College of New Jersey and a DMD from Boston University School of Dentistry. Dr. Meinecke maintains a private practice in Potomac, Maryland.
President – Jeff Urban
President-Elect – Murtuza Jaffari
Vice-President – Narpat Jain
Treasurer – Luciano Ghisalberti
Secretary – George Schmidt
From left to right
Dr. Narpat Jain: Secretary
Dr. Jeff Urban: President Elect
Dr. Vaidya Selvan: President
Dr. Louis Ghisalberti: Treasurer
Dr. Evan Wasserman: Past President
Not pictured: Dr. Murtzua Jaffari: Vice President
Event took place on May 11, 2016 in East Windsor, NJ
Officers installed on May 11, 2016 in East Windsor, NJ by Dr. Evan Wasserman
Are you a rising 4th year contemplating your future? If so, join us at the Garden State Dental Conference for an intimate look at the residency programs available to you in and around New Jersey. Last year 12 GPR programs participated in our fair. Join colleagues from area dental schools and begin your professional journey with the support of the state’s largest dental organization, the New Jersey Dental Association.
The Board of Directors of the New Jersey Academy of General Dentistry (NJAGD) in accordance with the NJAGD Constitution and By-Laws is posting, more then 90 days prior to the NJAGD Annual Session on May 11,2016 the nominating report:
Additional nominations of qualified candidates may be made by the membership by petition. Nominations by petition must be signed by fifteen (15) members of the NJAGD and must be submitted to NJAGD headquarters no less than forty five (45) prior to the Annual Meeting/Election. For the year 2016 petition must be received by March 26, 2016.
Required qualifications for each office: (President-Elect automatically moves to President)
President-Elect – A candidate for the office of President-Elect shall have either (1) been an officer of the NJAGD or (2) served at least two years on the Board of Directors.
Vice-President – A candidate for the office of Vice-President shall have either (1) been and officer of the NJAGD (2) served at least two years on the Board of Directors.
Treasurer – A candidate for the office of Treasurer must be an active member of the NJAGD
Secretary – A candidate for the office of Secretary must be an active member of the NJAGD
The State of New Jersey has established a Drug Control Unit within the Department of Law and Public Safety, for the purpose of assisting in the enforcement of those provisions of the New Jersey Controlled Dangerous Substances (CDS) Act which relate to persons who, or firms that, manufacture, prescribe, distribute, dispense or conduct research or analysis utilizing controlled substances.
The Drug Control Unit is also responsible for the administration of the NJPB Program.
For complete details please visit the NJDCU website.
Please be advised that beginning March 1, 2015, pharmacies will be required to report information to the NJPMP on a daily basis using the ASAP 4.2 format. . Prescriptions must be reported to the database no more than one (1) business day after the date the controlled substance was dispensed. In order to help facilitate any software conversion that may be necessary, the NJPMP will defer enforcement until September 1, 2015.
For complete details please visit the NJPMP website.